Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin. Read more about Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin.
Inhibition of Mycobacterium tuberculosis AhpD, an element of the peroxiredoxin defense against oxidative stress. Read more about Inhibition of Mycobacterium tuberculosis AhpD, an element of the peroxiredoxin defense against oxidative stress.
Virucidal efficacy of soap and water against human immunodeficiency virus in genital secretions. Read more about Virucidal efficacy of soap and water against human immunodeficiency virus in genital secretions.
Effects of gender, AIDS, and acetylator status on intrapulmonary concentrations of isoniazid. Read more about Effects of gender, AIDS, and acetylator status on intrapulmonary concentrations of isoniazid.
Intrapulmonary pharmacokinetics of linezolid. Read more about Intrapulmonary pharmacokinetics of linezolid.
Effects of AIDS and gender on steady-state plasma and intrapulmonary ethambutol concentrations. Read more about Effects of AIDS and gender on steady-state plasma and intrapulmonary ethambutol concentrations.
Effects of AIDS and gender on steady-state plasma and intrapulmonary ethionamide concentrations. Read more about Effects of AIDS and gender on steady-state plasma and intrapulmonary ethionamide concentrations.
Single-dose intrapulmonary pharmacokinetics of rifapentine in normal subjects. Read more about Single-dose intrapulmonary pharmacokinetics of rifapentine in normal subjects.
Intrapulmonary concentrations of pyrazinamide. Read more about Intrapulmonary concentrations of pyrazinamide.
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. Read more about Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.
